Narendra Wajapeyee PhD

Assistant Professor of Pathology

Departments & Organizations

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Medicine, Pharmacology, and Physiology

Signal Transduction

Pathology: Wajapeyee Lab | ExPath


Research Interests

Genetic and epigenetic mechanisms of cancer initiation and progression  more...


Education

  • Ph.D., Indian Institute of Science, India, 2005

Selected Publications

  • Sanchita Bhatnagar, Claude Gazin, Lynn Chamberlain, Jianhong OU, Xiaochun Zhu, Jogender S. Tushir, Ching-Man Virbasius, Ling Lin, LIhua J. Zhu, Narendra Wajapeyee and Michael R. Green. Trim37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein. Nature (in press), 2014.
  • Romi Gupta, Yuying Dong, Peter D. Solomon, Hiromi I Wettersten, Christopher Cheng, Jin-Na Min, Jeremy D. Henson, Shaillay K. Dogra, Sung H. Hwang, Bruce D. Hammock, Lihua J. Zhu, Roger R. Reddel, W. Mark Saltzman, Robert H. Weiss, Sandy Chang, Michael R. Green and Narendra Wajapeyee. Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A. Proc Natl Acad Sci USA, July 29th, 2014: 111(30):E3062-71.
  • Matteo Forloni, Shaillay Kumar Dogra, Yuying Dong, Darryl Conte Jr, Jianhong Ou, Lihua Julie Zhu, April Deng, Meera Mahalingam, Michael R. Green and Narendra Wajapeyee. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling. Elife, Feb 18; 3:e01460.2014

more...

collapsible-single-column-one-thumbnailphotobooksupi=13310903/WCF/News.svc/

Latest News

3
more...

Edit Profile